Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma

収録刊行物

• J Clin Oncol

  J Clin Oncol 16 1743-1751, 1998